- Why more spine procedures may never return to the hospital
- Digital extortion group threatens to leak data from One Medical senior health unit
- UPMC hospital opens $8M interventional radiology suite
- C-suite roles leading to ‘CEO’ in 2026
- UT Southwestern opens psychiatric hospital
- The CMS citations gaining, losing prevalence
- Turning stalled cases into surgical growth: 4 takeaways on how one orthopedic group found hidden revenue in smarter scheduling
- Hackensack Meridian to upgrade pediatric behavioral health tech
- 6 big pharma moves hospital pharmacists should know
- 5 medical device recalls to know
- Hospitals add pharmacists as retail workforce hits 15-year low: 5 notes
- 29% of US adults use AI for health information monthly: KFF
- ‘We’re not ready’: Care New England CDIO’s 3-to-5 year warning on AI
- 4 health system smart room investments
- Oregon State Hospital back in compliance after 2 years
- New Orleans East Hospital breaks ground on 1st inpatient behavioral health unit
- The physician career platform built by clinicians just hit 100,000 users
- What PE ownership actually does to physician practices
- Midlife Strength Training Linked to Lower Diabetes Risk
- Sunscreen Misinformation Popular On TikTok, Study Finds
- Patient Portal Messages Double, Doctors Face Rising Workload
- Most Americans Unaware Of Link Between Alcohol And Cancer — And Aren't Interested In Spreading The Word, Either
- Kids’ Juice And Soda Intake Linked To Higher Blood Pressure Risk As Young Adults
- Indiana Takes On Powerful Hospitals By Capping Prices They Charge Employers
- Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
- Worried About Your Aging Parents? Welcome to the Caregiving Club
- Novartis’ ‘Relax Your Tight End’ prostate cancer campaign wins Cannes Lions Pharma Grand Prix
- ‘I would love to tell Mark Cuban to get involved’: What physician consolidation is costing patients
- Illinois passes bill regulating dental reimbursement practices
- The shifting dental care landscape
- Harvard to end faculty dental practice, transfer clinic to private owner due to financial constraints
- A physician’s plan to bring back practice autonomy to South Carolina
- Cardiologists push back on expansion of WISeR model
- Are ASCs ready for CMS’ new oversight rules?
- MCNA Dental agrees to multimillion-dollar settlement over 2023 ransomware attack
- Former Iowa dental office employee accused of using patient financial information for personal purchases
- Optum Behavioral Health names chief medical officer
- Stark law’s $632 million reckoning: The 5 biggest cases in 5 years
- ASCs’ robot evidence problem
- United Concordia expands dental coverage for patients with chronic conditions
- OIG flags Pennsylvania behavioral insurer for faulty prior auth denials
- Independence Health to open 28-bed behavioral health unit
- ICON Dental Partners appoints VP of dental partnerships
- These 'socially responsible' hospitals deliver on quality, value and equity
- A look at Elevance Health's push to streamline clinical reviews
- Heartland Dental adds Missouri practice
- 4 dentists making headlines
- Growing ketamine use raises safety concerns
- AI’s growing role in mental healthcare: 5 notes
- Whistleblower suit accuses Genentech, Novartis of running decades-long kickback scheme on allergy med Xolair
- Big obesity bets and China's rise fuel potential $2T in 2032 drug sales: Evaluate
- Patient portal messages doubled since 2020, study finds, underscoring challenges to physician workloads
- HCSC unveils Easify Edge plans as alternative employer option
- Clover Hill Dairy Recalls All Cheese in Deadly Listeria Outbreak
- Ensemble Health Partners secures strategic growth investment from Thoreau
- Hospital margins inched higher in April, but still remain below 2025
- Middle-Aged Women Drink More, Know Less About Breast Cancer Risk
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- CARsgen makes history as China approves world's first CAR-T therapy for solid tumors
- High Hurdles Thwart Kidney Patients' Pursuit Of Life-Saving Transplants
- Rising Healthcare Costs Leave Many Americans Less Secure
- Short Videos Help First-Time Dads Learn Newborn Safety Basics
- Federal Push To Increase U.S. Primary Care Docs Has Fizzled, Study Says
- US to investigate Germany's proposed drug spending reforms
- Alnylam scolded over promotional activity after Pfizer complaint
- Real-world data powers next-gen biopharma
- They're Uninsured After Obamacare Became Too Costly. And They're Far From Alone.
- Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers
- Prosper AI lands $30M backed by Andreessen Horowitz to build AI workforce for healthcare operations
- Eli Lilly, Novo Nordisk top AI citation share as new report questions DTC spend culture
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- A 5-month sprint: Behind Pfizer’s $10B deal and Innovent’s global pharma ambition
- 1st free dental clinic opens in New Jersey
- 8 new behavioral health projects to know
- Rural, independent Kansas hospitals launch clinically integrated network
- FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition
- Congressional Budget Office calls for more research on No Surprises Act unintended impacts
- HHS opens applications for $700M in mental health, addiction funding, with $96M for new STREETS program
- Ebola Infections Climb, Could Take Year To Contain, Health Officials Say
- Why a deviation investigation still takes two weeks in the age of AI
- Feeling Sleepy During the Day? It Could Be a Warning Sign for High Blood Pressure
- FTC, states sue transgender health association over 'misleading' gender care guidance
- Healthcare organizations still struggle to operationalize AI at scale: Arcadia survey
- Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
- Major League Pitchers Might Avoid Elbow Injuries By Altering Their Approach, Simulation Suggests
- Birth Control Pills Might Increase Binge Eating Risk, Study Finds
- Women Might Lower Their Heart Risk By Lifting Weights, Study Says
- Personalized Brain Implant Provides Step-By-Step Walking Boost For Parkinson's Patients
- Amid industry’s cell therapy automation push, Cellares and Ori dominate the field: report
- Most Americans Are Surviving Cancer. But The Mental Health Challenges Can Persist.
- Listen to the Latest ‘KFF Health News Minute’
- Readers Curse Medical Debt and Defend Spelling Therapy
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Arrests of Immigrant Parents Create Mental Health Crisis for Children
- Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix
- Preparing for LEAD: Why post-acute visibility is the key to long-term value-based success
- One Medical Seniors reports data breach of third-party vendor impacting 'limited' number of patients
- A look at Epic's long-term play to build tech for operations, starting with scheduling
- U.K. Moves To Ban Social Media For Children
- Pregnant Woman Exposed to 45 Common Chemicals, Study Finds
- OhioHealth reaches settlement with DOJ, Ohio AG on antitrust lawsuit
- 4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line
- Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer
- OIG report raises red flags about maternal health 'ghost networks' in Medicaid managed care
- Why It’s Time to Sunset AI Point Solutions and Consolidate Platforms
- Lantern, Marathon Health team up to launch integrated care management model
- The New Frontier of Care Management: Bridging the Empathy Gap with Intelligence
- Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility
- GSK runs first DTC ad for would-be asthma blockbuster Exdensur
- Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports
- After FDA sign-off, Colorado's drug import plan faces tough road ahead
- Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs
- Surgical Menopause Tied To Worse Sexual And Urinary Symptoms
- Post-Op Delirium Common In Seniors, But Not All Hospitals Screen For It
- Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup
- Weekly Rundown: Lumeris adds symptom-checking tool to AI platform; DeepIntent rolls out agentic AI tool for healthcare marketers
- Before you build or buy care navigation AI, answer this
- Early-Onset Cancers Are On The Rise. Knowing Your Family History Is Crucial.
- Minimally Invasive Procedure Eases Arthritis Knee Pain, Study Finds
- Tennessee Pharmacies Sell Potent Ivermectin, Led by Anti-Vaccine Doctor Who’s Taken ‘Bucketloads’
- More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
- Democrats Seek To Spotlight Rising Health Costs by Forcing Vote on Trump Regulation
- Big Pharma’s Big Brand: Inside Eli Lilly’s marketing culture
- CDC, FDA Tackle New World Screwworm, Including Drug Authorization
- Lifestyle Changes Can Reduce Your Risk For Multiple Chronic Diseases
- People Walk, Exercise Less After Starting Ozempic, Zepbound
- Family Finances Shape Children’s Brain Development, Study Finds
- At-Home Blood Pressure Monitoring Reduces Risk of Heart Attack, Stroke
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Many Men Are Prescribed Testosterone Without Proper Testing
- Organic Baby Formula Recalled Following Botulism Cases
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks at the Investor Advisory Committee Meeting
Michigan healthcare freedom community forum
Child deaths from marijuana ingestion increase after each state legalization. Packaging marijuana edibles like popular foot items sure doesn't help.
Commission demands firms immediately change unfair and deceptive packaging
July 5, 2023
As part of its ongoing monitoring of health-related advertising claims, the Federal Trade Commission today sent cease and desist letters – jointly with the U.S. Food and Drug Administration (FDA) – to six companies currently marketing edible products containing Delta-8 tetrahydrocannabinol (THC) in packaging that is almost identical to many snacks and candy children eat, including Doritos tortilla chips, Cheetos cheese-flavored snacks, and Nerds candy.
“Marketing edible THC products that can be easily mistaken by children for regular foods is reckless and illegal,” said Samuel Levine, Director of the FTC’s Bureau of Consumer Protection. “Companies must ensure that their products are marketed safely and responsibly, especially when it comes to protecting the well-being of children.”
“Children are more vulnerable than adults to the effects of THC, with many who have been sickened and even hospitalized after eating ‘edibles’ containing it. That’s why we’re issuing warnings to several companies selling copycat food products containing delta-8 THC, which can be easily mistaken for popular foods that are appealing to children and can make it easy for a young child to ingest in very high doses without realizing it,” said Janet Woodcock, M.D., Principal Deputy Commissioner, FDA.
The agencies sent letters to the following companies: 1) Delta Munchies LLC (Los Angeles, California); 2) Exclusive Hemp Farms (Gilroy, California) and Etienne-DuBois, LLC/Oshipt (Henrico, Virginia); 3) North Carolina Hemp Exchange, LLC, dba NC Hemp Shoppe (Raleigh, North Carolina; 4) Dr. Smoke, LLC, aka Dr. S, LLC (Kansas City, Missouri); 5) Nikte's Wholesale, LLC (Albuquerque, New Mexico); and 6) The Haunted Vapor Room (Franklin, New Jersey).
According to the letters, after reviewing online marketing for Delta-8 THC products sold by the six companies, the FTC has determined that their advertising may violate Section 5 of the FTC Act, which prohibits unfair or deceptive acts in or affecting commerce, including practices that present unwarranted health or safety risks. The letters stress that preventing practices that present such risks, particularly to children, is one of the Commission’s highest priorities, and that imitating non-THC-containing food products that children consume is misleading.
The companies’ Delta-8 THC products mimic a range of food that appeal to children. Dr. Smoke, LLC, for example, sells THC-infused “Doritos” that are marketed in packaging that is nearly the same as that of Doritos Nacho Cheese Flavored Tortilla Chips (see graphic), including using the same red background, the use of the Doritos name and triangle logo, and the depiction of two tortilla chips in the same position. In addition, Dr. Smoke’s THC-infused “Cheetos” are sold in packaging that is nearly identical to that of Cheetos Crunchy Flamin’ Hot Cheese Flavored Snacks, right down to the use of the Chester Cheetah mascot.
Another company, The Haunted Vapor Room, sells Delta-8 THC products called Rope 500mg Delta-8 Nerds Candy and Medicated Dope Rope Bites (see graphic) that closely resemble Nerds Rope candy, with both comprising multi-colored crunchy candies attached to a gummy rope, and packaging for the former using what appears to be the Nerds candy mascot.
A third company, Delta Munchies, LLC, markets Delta-8 THC gummies that look like conventional gummy candies that are often consumed by children (see graphic). The brightly colored packaging includes images of the products in fruity and sour flavors that the FTC contends enhance their appeal to children and increases the likelihood that they will mistakenly eat them, thinking they are traditional gummy candies.
In the letters, the FTC demands the companies stop marketing edible Delta-8 THC products that imitate conventional foods using advertising or packaging that is likely to appeal to young children. The FTC also strongly encourages the sellers to review all of their marketing and product packaging for similar edible THC products, and to take swift action and steps to protect consumers, especially young children, from these products.
Finally, the FTC has asked each company to contact agency staff within 15 days to detail the specific actions it has taken to address the Commission’s concerns. The primary staff attorney on this matter is Christine DeLorme in the FTC’s Bureau of Consumer Protection.
Colorful graphics for specific products are shown in article photos.
Published yesterday by the Annals of Internal Medicine, a response to one of the pre-legalization claims: that medical marijuana access would help chronic pain patients transition from standard pain medications.
The article is eligible for CME Point-of-Care and MOC credits.
Full research accessible from the summary page: https://doi.org/10.7326/M23-0053
Original Research | 4 July 2023By Emma E. McGinty, PhD, Kayla N. Tormohlen, PhD, Nicholas J. Seewald, PhD, Mark C. Bicket, MD, PhD, Alexander D. McCourt, JD, PhD, Lainie Rutkow, JD, PhD, Sarah A. White, MS, and Elizabeth A. Stuart, PhDEffects of U.S. State Medical Cannabis Laws on Treatment of Chronic Noncancer Pain
Abstract
Background:
State medical cannabis laws may lead patients with chronic noncancer pain to substitute cannabis in place of prescription opioid or clinical guideline–concordant nonopioid prescription pain medications or procedures.
Objective:
To assess effects of state medical cannabis laws on receipt of prescription opioids, nonopioid prescription pain medications, and procedures for chronic noncancer pain.
Design:
Using data from 12 states that implemented medical cannabis laws and 17 comparison states, augmented synthetic control analyses estimated laws’ effects on receipt of chronic noncancer pain treatment, relative to predicted treatment receipt in the absence of the law.
Setting:
United States, 2010 to 2022.
Participants:
583 820 commercially insured adults with chronic noncancer pain.
Measurements:
Proportion of patients receiving any opioid prescription, nonopioid prescription pain medication, or procedure for chronic noncancer pain; volume of each treatment type; and mean days’ supply and mean morphine milligram equivalents per day of prescribed opioids, per patient in a given month.
Results:
In a given month during the first 3 years of law implementation, medical cannabis laws led to an average difference of 0.05 percentage points (95% CI, −0.12 to 0.21 percentage points), 0.05 percentage points (CI, −0.13 to 0.23 percentage points), and −0.17 percentage points (CI, −0.42 to 0.08 percentage points) in the proportion of patients receiving any opioid prescription, any nonopioid prescription pain medication, or any chronic pain procedure, respectively, relative to what we predict would have happened in that month had the law not been implemented.
Limitations:
This study used a strong nonexperimental design but relies on untestable assumptions involving parallel counterfactual trends. Statistical power is limited by the finite number of states. Results may not generalize to noncommercially insured populations.
Conclusion:
This study did not identify important effects of medical cannabis laws on receipt of opioid or nonopioid pain treatment among patients with chronic noncancer pain.
Primary Funding Source:
National Institute on Drug Abuse.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















